Clinical Trials for Metastatic Lung Cancer

Find clinical trials for metastatic lung cancer. Discover research opportunities and treatment options in your area.

18 Active Trials Found

Showing 18 trials on this page

Page 1 of 1

Open-Label Study of BBO-10203 in Subjects With Advanced Solid Tumors

NCT ID: NCT06625775

The BREAKER-101 clinical trial is a study looking at a new treatment called BBO-10203 for patients with advanced solid tumors, including certain types of breast and colorectal cancers. This is the ...

Recruiting

Phase: PHASE1 Type: interventional Locations: Boston, Massachusetts, United States, New York, New York, United States +13 more

Phase 1/2 Study of BDTX-1535 in Patients With Glioblastoma or Non-Small Cell Lung Cancer With EGFR Mutations

NCT ID: NCT05256290

This clinical trial is studying a new treatment called BDTX-1535 for adults with specific types of lung cancer and glioblastoma, which is a type of brain cancer. The trial aims to find out how safe...

Recruiting

Phase: PHASE1 Type: interventional Locations: Lebanon, New Hampshire, United States, Baltimore, Maryland, United States +88 more

Open-label Study of BBO-8520 in Adult Subjects With KRASG12C Non-small Cell Lung Cancer

NCT ID: NCT06343402

This clinical trial is testing a new treatment called BBO-8520 for adults with certain types of advanced cancer, specifically non-small cell lung cancer and colorectal cancer that have a specific c...

Recruiting

Phase: PHASE1 Type: interventional Locations: Salt Lake City, Utah, United States, Cleveland, Ohio, United States +14 more

A Study of BDTX-4933 in Patients With KRAS, BRAF and Select RAS/MAPK Mutation-Positive Cancers

NCT ID: NCT05786924

This clinical trial is studying a new medication called BDTX-4933, which is being tested in patients with certain types of advanced cancers that have specific genetic mutations, like those found in...

Recruiting

Phase: PHASE1 Type: interventional Locations: Seattle, Washington, United States, New York, New York, United States +14 more

Combination Therapies With Adagrasib in Patients With Advanced NSCLC With KRAS G12C Mutation

NCT ID: NCT05609578

This clinical trial, called CA239-0010, is exploring a new treatment approach for patients with advanced non-small cell lung cancer (NSCLC) who have a specific genetic mutation known as KRAS G12C. ...

Recruiting

Phase: PHASE2 Type: interventional Locations: Rochester, Minnesota, United States, Chicago, Illinois, United States +212 more

Definitive Radiation for High-Risk Spine Metastases

NCT ID: NCT06165419

This clinical trial is exploring a treatment option for patients with cancer that has spread to the spine. Specifically, it is looking at whether using a targeted type of radiation therapy, known a...

Recruiting

Phase: PHASE2 Type: interventional Locations: Stony Brook, New York, United States

Exercise as Maintenance Therapy in Advanced Lung Cancer

NCT ID: NCT06513663

This clinical trial is exploring how a special exercise program can help people with advanced lung cancer live better and longer. The study focuses on patients with a specific type of lung cancer c...

Recruiting

Phase: NA Type: interventional Locations: Indianapolis, Indiana, United States, Indianapolis, Indiana, United States +1 more

Safety and Efficacy of OBX-115 in Advanced Solid Tumors

NCT ID: NCT06060613

This clinical trial is studying a new treatment called OBX-115 for adults with advanced solid tumors, such as metastatic melanoma and non-small cell lung cancer. The main goal of the trial is to se...

Recruiting

Phase: PHASE1 Type: interventional Locations: Louisville, Kentucky, United States, Columbus, Ohio, United States +15 more

Phase 1 Trial of SYNC-T - Immunotherapy for Patients With Advanced/Metastatic Solid Tumors

NCT ID: NCT05544240

This clinical trial is studying a new treatment called SYNC-T, which is an immunotherapy designed to help patients with advanced or metastatic solid tumors, including types like metastatic breast c...

Recruiting

Phase: PHASE1 Type: interventional Locations: Mexico City, , Mexico

Vapor Ablation for Localized Cancer Lesions

NCT ID: NCT03514329

This clinical trial is investigating a new procedure called Bronchoscopic Thermal Vapor Ablation (BTVA-C) for treating localized lung cancer, specifically focusing on patients with non-small cell l...

Not yet recruiting

Phase: NA Type: interventional Locations: Vienna, , Austria, Ancona, , Italy

Description of Neurocognitive and Psychiatric Disorders Associated with Targeted Therapies Used in the Treatment of Lung Cancers with ALK/ROS1 Fusion and Their Impact on Patients' Quality of Life: Construction of an Experimental Patient-researcher Collaborative Care and Research Pathway

NCT ID: NCT06781905

The DRACONIS project is a clinical trial aimed at understanding the brain and mood problems that some patients with lung cancer experience while being treated with targeted therapies, specifically ...

Not yet recruiting

Type: observational Locations: Bron, , France, Bron, , France

The Impact of Radiotherapy on Oligometastatic Cancer

NCT ID: NCT05933876

This clinical trial is studying how a specific type of radiation treatment, called Stereotactic Ablative Radiotherapy (SABR), can help patients with oligometastatic cancer. Oligometastatic cancer m...

Recruiting

Type: observational Locations: Barcelona, , Spain, Barcelona, , Spain +19 more

Prospective, Longitudinal Biocollection in Thoracic Oncology, Including Newly Diagnosed Lung Cancer Patients

NCT ID: NCT06481813

This clinical trial is focused on collecting important health information from patients with lung cancer, specifically those newly diagnosed with different types of lung cancer, such as non-small c...

Not yet recruiting

Phase: NA Type: interventional

Pulse Radiotherapy to Overcome Metastatic Immune System Evasion in Lung Cancer

NCT ID: NCT06622174

This clinical trial is studying a new treatment approach for patients with advanced non-small cell lung cancer (NSCLC) that has not responded to standard immunotherapy. The researchers want to see ...

Not yet recruiting

Phase: PHASE1 Type: interventional Locations: Montréal, Quebec, Canada

LIquid Biopsy to prEdict Responses To First-line immunotherapY in Metastatic Non-small Cell LUNG Cancer. LIBERTY LUNG

NCT ID: NCT04790682

The LIBERTY LUNG trial is researching how a special blood test, called a liquid biopsy, can help predict how well patients with metastatic non-small cell lung cancer (NSCLC) will respond to initial...

Recruiting

Phase: NA Type: interventional Locations: Boulogne Billancourt, , France, Paris, , France +1 more

A Phase 1 First-In-Human Study of the Anti-CD73 IPH5301 Alone or in Combination With Chemotherapy and Trastuzumab in Patients With Advanced Solid Tumors

NCT ID: NCT05143970

This clinical trial, called CHANCES-IPC 2021-008, is exploring a new treatment called IPH5301 for patients with advanced solid tumors, which are cancers that have spread to other parts of the body....

Recruiting

Phase: PHASE1 Type: interventional Locations: Marseille, , France

Single-drug Chemotherapy Plus Immunotherapy in Metastatic Non-small Cell Lung Cancer Elderly Patients

NCT ID: NCT06032052

This clinical trial is looking at how effective and safe a combination of single-drug chemotherapy and immunotherapy is for elderly patients (65 years and older) who have advanced non-small cell lu...

Recruiting

Phase: PHASE2 Type: interventional Locations: Wuhan, Hubei, China

Fecal Microbiota Transplantation With Immune Checkpoint Inhibitors in Lung Cancer

NCT ID: NCT05502913

This clinical trial is investigating whether a treatment called Fecal Microbiota Transplant (FMT) can improve the effectiveness of immunotherapy for patients with metastatic lung cancer. Immunother...

Recruiting

Phase: PHASE2 Type: interventional Locations: Beer Sheva, , Israel, Petah Tikva, , Israel

Related Conditions

Breast Cancer View clinical trials → Stroke View clinical trials → Obesity View clinical trials → Cancer View clinical trials → Healthy View clinical trials → Prostate Cancer View clinical trials →

Search All Trials Browse All Conditions